Ivermectin for asymptomatic infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jun 2020: Trial registered, NCT04435587
  2. 13 Jul 2020: Trial started, NCT04435587

The trials

NCT04435587: Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

State
State not given
Phase
Phase 4
People
80 planned
Started
13 Jul 2020
Primary completion
Jun 2021
Arms
ivermectin
Results
None posted
  1. 17 Jun 2020: Trial registered
  2. 13 Jul 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.